A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
AstraZeneca
Eisai Inc.
PMV Pharmaceuticals, Inc
NeoImmuneTech
Genmab
Tubulis GmbH
Sumitomo Pharma America, Inc.
Bristol-Myers Squibb
Genmab
NEC Bio B.V
Exscientia AI Limited
Shenzhen Majory Biotechnology Co., Ltd.
Nanjing Leads Biolabs Co.,Ltd
AstraZeneca
Gilead Sciences
Radiopharm Theranostics, Ltd
Onchilles Pharma Inc
Ocellaris Pharma, Inc.
Jacobio Pharmaceuticals Co., Ltd.
Apollo Therapeutics Ltd
Seagen Inc.
Transgene
Avenzo Therapeutics, Inc.
BicycleTx Limited
Pfizer
BicycleTx Limited
Volastra Therapeutics, Inc.
Strand Therapeutics Inc.
ITM Oncologics GmbH
Immunitas Therapeutics
Scancell Ltd
CytoDyn, Inc.
A2 Biotherapeutics Inc.
TCR2 Therapeutics
Incyte Corporation
Medicenna Therapeutics, Inc.
TransThera Sciences (Nanjing), Inc.
Formation Biologics
Bristol-Myers Squibb
Numab Therapeutics AG
SK Life Science, Inc.
Gilead Sciences
Cantargia AB
Lantern Pharma Inc.
BioLite, Inc.
BeiGene
BioAtla, Inc.
Cyteir Therapeutics, Inc.
Sellas Life Sciences Group